Horizon Therapeutics Plc Watch

from 8-K 165 pages Credit Agreement Dated as of May 7, 2015 Among Horizon Pharma, Inc., as Borrower, Horizon Pharma Public Limited Company, as Irish Holdco and a Guarantor, the Subsidiary Guarantors Party Hereto, as Subsidiary Guarantors the Lenders Party Hereto, and Citibank, N.A., as Administrative Agent and Collateral Agent Citigroup Global Markets Inc. and Jefferies Finance LLC, as Co-Syndication Agents, Citigroup Global Markets Inc. and Jefferies Finance LLC, as Co-Documentation Agents and Citigroup Global Markets Inc. and Jefferies Finance LLC, as Joint Bookrunners and Joint Lead Arrangers

from 10-K 5 pages Third Loan Modification Agreement

from 8-K 96 pages Loan and Security Agreement Dated as of February 22, 2012 Among Horizon Pharma USA, Inc. and Horizon Pharma, Inc. (As Borrowers), Cortland Capital Market Services LLC (As Administrative Agent) and the Other Lenders Party Hereto Loan and Security Agreement

from 10-Q 4 pages Second Loan Modification Agreement

from 10-Q 5 pages Consent and First Loan Modification Agreement

from S-1/A 27 pages Second Amendment to Agreement for the Provision of a Loan Facility of Up to Euro 7,500,000

from S-1/A 10 pages Dated June 2, 2011 Kreos Capital III (Uk) Limited Horizon Pharma, Inc. Horizon Pharma AG and Oxford Finance LLC Deed of Assignment and Postponement Speechly Bircham Llp 6 New Street Square London Ec4a 3lx Tel: +44 (0)20 7427 6400 Fax: +44 (0)20 7427 6600 This Deed Is Dated June 2, 2011 Parties (1) Kreos Capital III (Uk) Limited, a Company Incorporated in England and Wales, With Registered Number 05981165, Whose Registered Office Is at 25-28 Old Burlington Street, London W1s 3an (The Assignor); (2) Horizon Pharma, Inc., a Company Incorporated in Delaware, U.S.A (The Assignee); (3) Horizon Pharma AG (Formerly Nitec Pharma AG), a Company Incorporated in Switzerland With Number Ch-280.3.007-0/ (The Borrower); and (4) Oxford Finance LLC, a Delaware Limited Liability Company, in Its Capacity as the Administrative Agent Under the US Loan Agreement (As Defined Below) (The Subordinated Creditor). Background (A) the Assignor Is the Lender Under the Facility Agreement (As Defined Below). (B) the Assignor Has Advanced Monies to the Borrower Under the Facility Agreement. (C) the Assignor Has Agreed to Assign All Its Legal and Beneficial Right, Title and Interest in the Assigned Debt (As Defined Below) to the Assignee on the Terms and Conditions Set Out Below. (D) the Assignee Has Agreed to the Subordination of the Borrower Debt (As Defined Below). (E) the Subordinated Creditor Has Agreed to Subordinate the Subordinated Creditor Debt (As Defined Below). Agreed Terms 1. Definitions and Interpretation

from S-1/A 70 pages Loan and Security Agreement Dated as of June 2, 2011 Among Horizon Pharma USA, Inc., Horizon Pharma, Inc., and Horizon Pharma (Uk) Limited, (As Borrowers), Oxford Finance LLC (As Administrative Agent) and the Other Lenders Party Hereto

from S-1/A 26 pages First Amendment to Agreement for the Provision of a Loan Facility of Up to Euro 7,500,000

from S-1 26 pages First Amendment to Agreement for the Provision of a Loan Facility of Up to Euro 7,500,000

from S-1 18 pages Agreement for the Provision of a Loan Facility of Up to Euro 7,500,000 Date 15/8/2008 Between

from S-1 68 pages Loan and Security Agreement Dated as of April 1, 2010 Among Horizon Pharma USA, Inc. and Nitec Pharma AG, (As Borrowers), Horizon Pharma, Inc. (As Guarantor), Kreos Capital III (Uk) Limited (As Administrative Agent) and the Other Lenders Party Hereto